Testing effectiveness (Phase 2)Looking for participantsNCT06907875
What this trial is testing
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc. 12